This article is more than 5 years old. Information may no longer be current.

Visian ICL with CentraFLOW gains regulatory approval in Argentina, Korea

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

Korea and Argentina have granted regulatory approvals to STAAR Surgical to market the Visian Implantable Collamer Lens with CentraFLOW technology, according to a press release.

CentraFLOW is designed to improve the flow of fluid within the eye, the release said. It eliminates the need for a YAG peripheral iridotomy several days before the Visian ICL is implanted.

For myopia, the Visian ICL with CentraFLOW is approved for –0.5 D to –18 D. For the toric ICL models, cylinder power ranges from +0.5 D to +6 D, according to the release.